Quick Answer
Century Therapeutics, Inc. reported Shares Outstanding of 87.52 million shares for fiscal year 2025.
Century Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 87.52M | +2.0% |
| 2024 | 85.84M | +42.3% |
| 2023 | 60.34M | +9.7% |
| 2022 | 55.01M | -5.9% |
| 2021 | 58.47M | +681.5% |
| 2020 | 7.48M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 86.53M | +2.3% | +0.2% |
| June 30, 2025 | 86.32M | +2.1% | +0.2% |
| March 31, 2025 | 86.15M | +42.8% | +0.4% |
| December 31, 2024 | 85.84M | +42.3% | +1.5% |
| September 30, 2024 | 84.55M | +42.1% | +0.0% |
| June 30, 2024 | 84.55M | +42.6% | +40.1% |
| March 31, 2024 | 60.34M | +2.1% | +0.0% |
| December 31, 2023 | 60.34M | +3.2% | +1.4% |
- Century Therapeutics, Inc. showed an increase of +2.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Century Therapeutics, Inc.’s shares outstanding has grown by 1069.8% (from 7.48 million shares to 87.52 million shares).
- The most recent figure is from Century Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: